pharma-company /Medicinal products /Active ingredients

Rx · PZN 13475319

DAXAS 250 µg tablets

German trade nameDAXAS 250 Mikrogramm Tabletten

Active ingredientRoflumilastPharmaceutical formTablets

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Highest known
purchase price (B2B)

~ €48

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

DAXAS 250 µg tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

DAXAS 250 µg tablets contains the active ingredient Roflumilast and comes as Tablets. One pack size is recorded (PZN 13475319). The pharma availability index for German wholesale stands at 9.6 out of 10 over the past 30 days – the pack was therefore consistently available.

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

More products containing Roflumilast

ROFLUM HEXAL 500 µg film-coated tablets9.6ROFLUMILAPUREN 500 µg tablets9.6ROFLUMILAST AL 500 µg film-coated tablets9.6ROFLUMILAST Abdi 500 µg film-coated tablets9.6ROFLUMILAST Heumann 250 µg tablets9.6
All 14 products containing Roflumilast →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.